Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We present a protocol to generate a minimally invasive orthotopic pancreatic cancer model by ultrasound-guided injection of human pancreatic cancer cells and the subsequent monitoring of tumor growth in vivo by ultrasound imaging.

Abstract

Pancreatic cancer (PCa) represents one of the deadliest cancer types worldwide. The reasons for PCa malignancy mainly rely on its intrinsic malignant behavior and high resistance to therapeutic treatments. Indeed, despite many efforts, both standard chemotherapy and innovative target therapies have substantially failed when moved from preclinical evaluation to the clinical setting. In this scenario, the development of preclinical mouse models better mimicking in vivo characteristics of PCa is urgently needed to test newly developed drugs. The present protocol describes a method to generate a mouse model of PCa, represented by an orthotopic xenograft obtained by ultrasound-guided injection of human pancreatic tumor cells. Using such a reliable and minimally invasive protocol, we also provide evidence of in vivo engraftment and development of tumor masses, which can be monitored by ultrasound (US) imaging. A noteworthy aspect of the PCa model described here is the slow development of the tumor masses over time, which allows precise identification of the starting point for pharmacological treatments and better monitoring of the effects of therapeutic interventions. Moreover, the technique described here is an example of implementation of the 3Rs principles since it minimizes pain and suffering and directly improves the welfare of animals in research.

Introduction

PCa, and its most common form, the Pancreatic Ductal Adeno Carcinoma (PDAC), is one of the most common causes of cancer-related death with a 1-year survival rate lower than 20% and a 5-year survival rate of 8%, regardless of the stage1,2. The disease is almost always fatal, and its incidence is forecasted to continuously grow in the next years, unlike other cancer types, whose incidence is declining3. Factors such as late cancer detection, the tendency of rapid progression, and lack of specific therapies lead to a poor prognosis of PCa4. Great advances in cancer ....

Protocol

The present protocol received approval from the Italian Ministry of Health with the authorization number 843/2020-PR. In order to ensure aseptic conditions, the animals were maintained inside the barrier room of the research animal vivarium (Ce.S.A.L.) of the University of Florence. All procedures were performed in the same space where the mice were housed at the LIGeMA facility of the University of Florence (Italy).

1. Cell preparation

  1. Culture PCa cells from the P.......

Representative Results

Following the protocol described above, mice were first anesthetized in an isoflurane chamber, and placed on the animal platform (Figure 1A). The pancreas was visualized with ultrasound imaging (Figure 1B). A 50 µL Hamilton syringe was loaded with 1 x 106 PANC1 cells suspended in 20 µL of PBS and placed on the needle holder (Figure 1C). The optimal angle between the syringe and the US transducer was 45° (

Discussion

Although the use of US imaging is widespread in the clinic, tumor development in many preclinical mouse models is usually described using bioluminescent imaging11. The latter is an indirect way to evaluate tumor engraftment and expansion and it also does not provide a reliable tumor growth kinetics. In the present study, we have applied US imaging for performing cell injection as well as for monitoring tumor development. The protocol we have described and the results we have provided represent a r.......

Acknowledgements

This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC, grant no. 15627, IG 21510, and IG 19766) to AA, PRIN Italian Ministry of University and Research (MIUR). Leveraging basic knowledge of ion channel network in cancer for innovative therapeutic strategies (LIONESS) 20174TB8KW to AA, pHioniC: European Union's Horizon 2020 grant No 813834 to AA. CD was supported by a AIRC fellowship for Italy ID 24020.

....

Materials

NameCompanyCatalog NumberComments
100 mm Petri dishSarstedt, GermanyP5856
3D-Mode packageVisualsonics Fujifilm, ItalyIncludes the 3D Motor; necessary for volumetric imaging
Aquasonic 100, Sonypack 5 lt Ultrasound Transmission GelPARKER LABORATORIES, INC.150Gel for ultrasound
Athymic Mice (Nude-Foxn1nu)ENVIGO, Italy6920 females, 8 weeks old, Athymic Nude-Foxn1nu, 20-22 g body weight
CO2 Incubator Function LineHeraeus Instruments, GermanyBB16-ICN2
Display of ECG, Respiration Waveform and body temperatureVisualsonics Fujifilm, Italy11426
DMEM (Dulbecco’s Modified Eagle Medium)Euroclone Spa, ItalyECM0101L
DPBS (Dulbecco’s Phosphate Buffered Saline)Euroclone Spa, ItalyECB4004L
Eppendorf (1.5mL)Sarstedt, Germany72.690.001
FBS (Fetal Bovine Serum)Euroclone Spa, ItalyECS0170L
Hamilton Needle Pointstyle 4, lenght 30 mm, 28 GaugePermax S.r.l., Italy7803-02
Hamilton Syringe 705RM 50 µLPermax S.r.l., Italy7637-01
Isoflo (250 mL)Ecuphar7081219
L-glutamine 100XEuroclone Spa, ItalyECB3000D
Mouse Handling table IIVisualsonics Fujifilm, Italy50249
MX550D: 55 MHz MX Series TransducerVisualsonics Fujifilm, Italy51069Ultrasound Transducers
Oxygen/isofluorane mixerAngelo Franceschini S.r.l.LFY-I-5A
PANC1 cell lineAmerican Type Culture Collection (ATCC), USACRL-1469
Rimadyl (carprofen)Pfizer1131920 mL, injection solution
Trypsin-EDTA 1X in PBSEuroclone Spa, ItalyECB3052D
Vet ointment for eyes, Systane nighttimeAlcon509/28555-1
Vevo Compact Dual Anesthesia System (Tabletop Version)Visualsonics Fujifilm, ItalyVS-12055complete with gas chamber
Vevo Imaging Station 2Visualsonics Fujifilm, ItalyVS-11983Imaging WorkStation 1 plus Imaging Station Extension with injection mount
Vevo LabVisualsonics Fujifilm, ItalyVS-20034Data Analysis Software
Vevo LAZR-X Photoacoustic Imaging SystemVisualsonics Fujifilm, ItalyVS-20054Includes analytic software package for B-mode
Vevo Photoacoustic EnclosureVisualsonics Fujifilm, Italy53157

References

  1. Zeng, S., et al. Chemoresistance in pancreatic cancer. International Journal of Molecular Sciences. 20 (18), 4504 (2019).
  2. Bray, F., et al. Global cancer statistics 2018: GLOBOCAN estimates of incid....

Explore More Articles

Orthotopic XenograftPancreatic CancerUltrasound guided InjectionMouse ModelPANC1 CellsB Mode ImagingMinimally Invasive3Rs PrinciplesSmall Molecules

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved